BIP
Bouvel Investment Partners’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.52M | Buy |
31,161
+9,458
| +44% | +$460K | 0.51% | 59 |
|
|
2025
Q1 | $1.02M | Sell |
21,703
-143
| -0.7% | -$6.72K | 0.38% | 64 |
|
|
2024
Q4 | $860K | Buy |
21,846
+143
| +0.7% | +$5.63K | 0.31% | 69 |
|
|
2024
Q3 | $1.02M | Sell |
21,703
-229
| -1% | -$10.8K | 0.38% | 64 |
|
|
2024
Q2 | $1.18M | Buy |
21,932
+4
| +0% | +$216 | 0.46% | 59 |
|
|
2024
Q1 | $1.49M | Buy |
21,928
+80
| +0.4% | +$5.45K | 0.65% | 54 |
|
|
2023
Q4 | $1.37M | Buy |
21,848
+942
| +5% | +$59K | 0.64% | 58 |
|
|
2023
Q3 | $949K | Buy |
20,906
+391
| +2% | +$17.7K | 0.51% | 62 |
|
|
2023
Q2 | $1.15M | Buy |
20,515
+558
| +3% | +$31.3K | 0.63% | 56 |
|
|
2023
Q1 | $903K | Buy |
19,957
+569
| +3% | +$25.7K | 0.53% | 58 |
|
|
2022
Q4 | $788K | Buy |
19,388
+662
| +4% | +$26.9K | 0.51% | 58 |
|
|
2022
Q3 | $1.22M | Buy |
18,726
+190
| +1% | +$12.4K | 0.82% | 48 |
|
|
2022
Q2 | $1.13M | Buy |
18,536
+226
| +1% | +$13.7K | 0.85% | 48 |
|
|
2022
Q1 | $1.15M | Buy |
18,310
+145
| +0.8% | +$9.1K | 0.7% | 54 |
|
|
2021
Q4 | $1.38M | Sell |
18,165
-214
| -1% | -$16.2K | 0.77% | 57 |
|
|
2021
Q3 | $2.06M | Sell |
18,379
-328
| -2% | -$36.7K | 1.16% | 41 |
|
|
2021
Q2 | $3.03M | Buy |
18,707
+20
| +0.1% | +$3.24K | 1.71% | 25 |
|
|
2021
Q1 | $2.28M | Sell |
18,687
-103
| -0.5% | -$12.6K | 1.46% | 32 |
|
|
2020
Q4 | $2.88M | Buy |
+18,790
| New | +$2.88M | 2.04% | 18 |
|